The transient receptor potential (TRP) ion channels comprise a diverse superfamily of cation channels that play pivotal roles in sensory transduction, enabling organisms to detect a wide range of ...
Astrazeneca AB has synthesized transient receptor potential cation channel subfamily V member 4 (TRPV4) antagonists reported to be useful for the treatment of inflammatory disorders, respiratory ...
Clinical Trials Arena on MSN
Boehringer Ingelheim’s kidney drug reduces proteinuria by 40% in Phase II trial
Data from Boehringer Ingelheim’s Phase II apecotrep study was published in The Lancet and presented at the 2025 ASN’s Kidney Week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results